# Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

> **NCT02255357** · PHASE2,PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 43 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Placebo
- **DRUG:** Intranasal Oxytocin

## Key facts

- **NCT ID:** NCT02255357
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-02-14
- **Final completion:** 2018-02-14
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255357, "Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02255357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*